Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    Invitrogen™ Phospho-FGFR Pan (Tyr653, Tyr654) Polyclonal Antibody
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5105938
Description
Antibody detects endogenous levels of FGFR1/2/3/4 only when phosphorylated at Tyr653+Tyr654.
This gene encodes a protein that is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. 
            Specifications
| Phospho-FGFR Pan (Tyr653, Tyr654) | |
| Polyclonal | |
| Unconjugated | |
| FGFR1 | |
| ACH; AU043015; AW208770; AW556123; bacteria-expressed kinase; basic fibroblast growth factor receptor 1; BBDS; BEK; BEK fibroblast growth factor receptor; BFGFR; bFGF-R; bFGF-R-1; BFR-1; CD331; CD332; CD333; CD334; CEK; CEK2; CEK3; CFD1; c-fgr; CTLA-2-beta protein; Eask; ECCL; ECT1; FGF receptor-1; FGFBR; fgfr 1; FGFR1; Fgfr-1; FGFR1/PLAG1 fusion; FGFR2; Fgfr-2; FGFR3; FGFR-3; FGFR4; FGFR-4; Fgfr7; Fgfr-7; fibroblast growth factor receptor 1; Fibroblast growth factor receptor 2; fibroblast growth factor receptor 3; fibroblast growth factor receptor 3 variant 4; fibroblast growth factor receptor 4; fibroblast growth factor receptor 4 16 minus form; Flg; Flg-2; FLT2; FLT-2; Fms-like tyrosine kinase 2; fms-related tyrosine kinase 2; FR3; HBGFR; heparin-binding growth factor receptor; HH2; HRTFDS; HSFGFR3EX; Hspy; hydroxyaryl-protein kinase; JTK2; JTK4; JWS; KAL2; Keratinocyte growth factor receptor; KGFR; KGFRTr; KSAM; K-sam; MFR; Mfr3; Mpk-11; N-sam; OGD; protein tyrosine kinase, receptor like 14; protein-tyrosine kinase; protein-tyrosine kinase receptor MPK-11; Proto-oncogene c-Fgr; sam3; svs; TK14; TK25; TKF; tyrosine kinase JTK4; tyrosine kinase related to fibroblast growth factor receptor; tyrosylprotein kinase | |
| Rabbit | |
| Sequential chromatography | |
| RUO | |
| 14182, 14183, 14184, 14186, 2260, 2261, 2263, 2264, 25022, 25114, 79114, 84489 | |
| -20°C | |
| Liquid | 
| Immunohistochemistry (Paraffin), Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| P11362, P16092, P21802, P21803, P22455, P22607, Q03142, Q04589, Q498D6, Q61851 | |
| FGFR1, FGFR2, FGFR3, FGFR4 | |
| A synthesized peptide derived from human FGFR1(Accession P11362), corresponding to amino acid residues around phosphorylated Tyr654. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat, Monkey | |
| Antibody | |
| IgG | 
Safety and Handling
                                                    
                                                    WARNING: Cancer - www.P65Warnings.ca.gov 
                                                
                                            
                                        
                                    
                                
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
             
                             
                             
                             
                             
                            